← All stocks

ENDRA Life Sciences Inc.

NDRA No buying or selling
CIK 0001681682 #5359 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

5 insiders · 0 transactions
0.4×

Alexander Tokman holds only 0.4 times base salary in stock. $56.29K of shares against $114.23K in salary for 2024.

Salary from the company's own proxy. The shares are what Alexander Tokman last reported holding, valued at $0.55, the price Common Stock was last bought or sold at on the open market here, on 27 Aug 2024.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
DIGIANDOMENICO ANTHONY
Director
136,589
$75.44K
+231,407%
Tokman Alexander Y
Chief Executive Officer
101,926
$56.29K
+2,038,420%
Harsh Michael
Director
65,710
$36.29K
+3,285,400%
Basenese Lou
Director
65,709
$36.29K
+6,570,800%
Jacroux Richard
Chief Financial Officer
33,461
$18.48K

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 536,908 to 1,499,838 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 8
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 387,176
History held since 16 May 2017